About 1 result found for searched term "2245053-57-8" (0.509 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M21076 | Etavopivat | Pyruvate Kinase |
| FT-4202 | ||
| Etavopivat, an oral erythrocyte pyruvate kinase activator, is being developed for sickle cell disease and other hemoglobinopathies, previously reported in 2019. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
